These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18353724)

  • 41. Versatile signaling through NKG2D.
    Long EO
    Nat Immunol; 2002 Dec; 3(12):1119-20. PubMed ID: 12447364
    [No Abstract]   [Full Text] [Related]  

  • 42. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways.
    Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC
    Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation.
    Wang H; Ruan Z; Wang Y; Han J; Fu X; Zhao T; Yang D; Xu W; Yang Z; Wang L; Chen Y; Wu Y
    Mol Immunol; 2008 Mar; 45(6):1548-56. PubMed ID: 18062910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the activating receptor NKG2D in autoimmunity.
    Van Belle TL; von Herrath MG
    Mol Immunol; 2009 Nov; 47(1):8-11. PubMed ID: 19286259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NKG2D function protects the host from tumor initiation.
    Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
    J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
    Carlsten M; Björkström NK; Norell H; Bryceson Y; van Hall T; Baumann BC; Hanson M; Schedvins K; Kiessling R; Ljunggren HG; Malmberg KJ
    Cancer Res; 2007 Feb; 67(3):1317-25. PubMed ID: 17283169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK cells and cancer immunosurveillance.
    Waldhauer I; Steinle A
    Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B; Khar A
    Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2D.
    Poggi A; Zocchi MR
    Clin Dev Immunol; 2006; 13(2-4):325-36. PubMed ID: 17162374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human natural killer lymphocytes through the engagement of natural cytotoxicity receptors and NKG2D can trigger self-aggression.
    Poggi A; Zocchi MR
    Autoimmun Rev; 2007 Apr; 6(5):295-9. PubMed ID: 17412301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The DNA damage response arouses the immune system.
    Gasser S; Raulet DH
    Cancer Res; 2006 Apr; 66(8):3959-62. PubMed ID: 16618710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
    Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
    J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
    Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
    Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
    Kaiser BK; Yim D; Chow IT; Gonzalez S; Dai Z; Mann HH; Strong RK; Groh V; Spies T
    Nature; 2007 May; 447(7143):482-6. PubMed ID: 17495932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.
    Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR
    Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese.
    Furue H; Matsuo K; Kumimoto H; Hiraki A; Suzuki T; Yatabe Y; Komori K; Kanemitsu Y; Hirai T; Kato T; Ueda M; Ishizaki K; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):316-20. PubMed ID: 18174257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
    Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.